SG46456A1 - Process for typing of hcv isolates - Google Patents

Process for typing of hcv isolates

Info

Publication number
SG46456A1
SG46456A1 SG1996004862A SG1996004862A SG46456A1 SG 46456 A1 SG46456 A1 SG 46456A1 SG 1996004862 A SG1996004862 A SG 1996004862A SG 1996004862 A SG1996004862 A SG 1996004862A SG 46456 A1 SG46456 A1 SG 46456A1
Authority
SG
Singapore
Prior art keywords
typing
viruses
hcv isolates
relates
present
Prior art date
Application number
SG1996004862A
Other languages
English (en)
Inventor
Geert Maertens
Lieven Stuyver
Rudi Rossau
Van Hugo Heuverswyn
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26132445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG46456(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of SG46456A1 publication Critical patent/SG46456A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996004862A 1992-11-27 1993-11-26 Process for typing of hcv isolates SG46456A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92403222 1992-11-27
EP93402129 1993-08-31

Publications (1)

Publication Number Publication Date
SG46456A1 true SG46456A1 (en) 1998-02-20

Family

ID=26132445

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004862A SG46456A1 (en) 1992-11-27 1993-11-26 Process for typing of hcv isolates

Country Status (13)

Country Link
US (8) US5846704A (fr)
EP (3) EP0905258A3 (fr)
JP (2) JP4251407B2 (fr)
AT (2) ATE507312T1 (fr)
AU (1) AU681612B2 (fr)
CA (1) CA2128528C (fr)
DE (2) DE69324678T2 (fr)
DK (1) DK0637342T3 (fr)
ES (1) ES2133529T3 (fr)
GR (1) GR3030641T3 (fr)
HK (1) HK1047961A1 (fr)
SG (1) SG46456A1 (fr)
WO (1) WO1994012670A2 (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69324678T2 (de) * 1992-11-27 1999-12-09 Naamloze Vennootschap Innogenetics S.A., Gent Verfahren zur typisierung von hcv-isolaten
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
CN1071977C (zh) * 1993-03-05 2001-09-26 杰姆斯达发展公司 使用压缩码作电视节目录像时间排定的装置与方法
EP0984068B1 (fr) * 1993-04-27 2012-03-28 Innogenetics N.V. Séquences des génotypes du virus de l'hépatite C et leurs utilisations comme agents thérapeutiques ou diagnostiques
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US5830635A (en) * 1995-03-31 1998-11-03 Agnello; Vincent Method of detecting hepatitis C virus in tissues
US20020081577A1 (en) * 1995-06-06 2002-06-27 Robert L. Kilkuskie Oligonucleotides speciific for hepatitis c virus
BR9704637A (pt) * 1996-01-26 1998-06-09 Innogenetics Nv Processo para deteção de mutações induzidas por droga no gene de transcrição reversa
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
FR2750505B1 (fr) * 1996-06-27 1998-10-16 Appligene Oncor Procede de preparation de supports d'analyse de substances chimiques ou biologiques presentant un ensemble ordonne de zones de reaction
CA2276462C (fr) 1996-12-31 2007-06-12 High Throughput Genomics, Inc. Procede et dispositif d'analyse moleculaire multiplexee
US7101672B2 (en) * 1998-05-05 2006-09-05 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
IL122299A (en) * 1997-11-25 2003-11-23 Broadcom Corp Video encoding device
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
WO1999060158A1 (fr) * 1998-05-19 1999-11-25 Laboratory Of Molecular Biophotonics Phase solide utilisee pour detecter de l'acide nucleique et procede de detection d'acide nucleique
AR019932A1 (es) 1998-07-17 2002-03-27 United Video Properties Inc Una disposicion de guias de programacion televisiva interactivas que tiene multiples dispositivos dentro de una residencia de un grupo familiar y un método que la emplea
AR020608A1 (es) 1998-07-17 2002-05-22 United Video Properties Inc Un metodo y una disposicion para suministrar a un usuario acceso remoto a una guia de programacion interactiva por un enlace de acceso remoto
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
AU2006203092B2 (en) * 1999-02-03 2009-11-12 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
US6623919B1 (en) * 1999-02-03 2003-09-23 Ortho-Clinical Diagnostics, Inc Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
GB0016836D0 (en) * 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
KR100461715B1 (ko) * 2001-03-27 2004-12-17 가부시끼가이샤 도시바 질환과 관련된 핵산의 검출 방법
WO2002090572A2 (fr) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Detection d'acides nucleiques dans des echantillons groupes
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US7877273B2 (en) * 2002-01-08 2011-01-25 Fredric David Abramson System and method for evaluating and providing nutrigenomic data, information and advice
GB0200526D0 (en) * 2002-01-11 2002-02-27 Science And Technology The Methods
FR2855832B1 (fr) 2003-06-03 2007-09-14 Biomerieux Sa Procede de diagnostic et/ou de pronostic d'un syndrome septique
FR2857375B1 (fr) 2003-07-10 2007-11-09 Biomerieux Sa Procede de detection et/ou d'identification de bacteries de genre staphylococcus
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
EP1536024B1 (fr) * 2003-08-29 2016-08-17 Fujirebio Europe N.V. Nouveau clade du virus de l'hepatite c et sequences prototypiques de celui-ci
CA2552949C (fr) 2004-01-07 2012-10-02 Third Wave Technologies, Inc. Determination d'un genotype du virus de l'hepatite c
US20090209432A1 (en) * 2004-04-06 2009-08-20 Flinders Technologies Pty. Ltd. Detecting targets using nucleic acids having both a variable region and a conserved region
US8806533B1 (en) 2004-10-08 2014-08-12 United Video Properties, Inc. System and method for using television information codes
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
US8927208B2 (en) 2005-03-30 2015-01-06 Labo Bio-Medical Investments B.V. Identification of beta-papillomavirus DNA by type-specific reverse hybridization
US7919242B2 (en) * 2005-06-30 2011-04-05 Roche Molecular Systems, Inc. Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
US20070207455A1 (en) * 2005-11-17 2007-09-06 Third Wave Technologies, Inc. Compositions and methods for detecting an HCV-1 subtype
WO2007087310A2 (fr) * 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Analyses d'acides nucléiques au moyen de marques de séquences
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
EP2527474A1 (fr) 2006-10-20 2012-11-28 Innogenetics N.V. Méthodologie d'analyse des variations de séquence dans la zone génomique HCV NS3/4A
EP2463390A1 (fr) 2006-10-20 2012-06-13 Innogenetics N.V. Méthode d'analyse des variations de séquence dans la zone génomique NS5B du VHC
US8418206B2 (en) 2007-03-22 2013-04-09 United Video Properties, Inc. User defined rules for assigning destinations of content
WO2009022939A1 (fr) * 2007-08-09 2009-02-19 Uchrezhdenie Rossiiskoi Akademii Nauk Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Ran (Imb Ran) Procédé d'identification du génotype et du sous-type du virus de l'hépatite c sur une biopuce
US8601526B2 (en) 2008-06-13 2013-12-03 United Video Properties, Inc. Systems and methods for displaying media content and media guidance information
KR101755037B1 (ko) 2008-12-29 2017-07-19 주식회사 엘지화학 핵산 염색제를 이용한 실시간 중합효소 연쇄반응을 통한 ｈｃｖ 검출방법
US20100240049A1 (en) * 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
CN102301008B (zh) 2009-01-19 2015-05-13 生物梅里埃公司 用于确定患者发生医院内感染的易感性以及确立败血性综合征进展的预后的方法
US20100323344A1 (en) * 2009-06-18 2010-12-23 Ferguson Monique R Detection of hepatitis C virus RNA
US9204193B2 (en) 2010-05-14 2015-12-01 Rovi Guides, Inc. Systems and methods for media detection and filtering using a parental control logging application
US9422598B2 (en) 2010-06-04 2016-08-23 Biomerieux Method and kit for the prognosis of colorectal cancer
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
FR2970975B1 (fr) 2011-01-27 2016-11-04 Biomerieux Sa Procede et kit pour determiner in vitro le statut immunitaire d'un individu
WO2012129758A1 (fr) 2011-03-25 2012-10-04 Biomerieux Procédé et kit pour déterminer in vitro la probabilité qu'un individu soit atteint d'un cancer colorectal
ES2640570T3 (es) * 2012-10-18 2017-11-03 F. Hoffmann-La Roche Ag Ensayo de doble sonda para la detección de VHC
FR3000966B1 (fr) 2013-01-11 2016-10-28 Biomerieux Sa Procede pour etablir in vitro un pronostic de severite chez un patient en choc septique
CN104178562B (zh) 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
WO2018075633A2 (fr) * 2016-10-19 2018-04-26 Gen-Probe Incorporated Compositions et méthodes de détection ou quantification du virus de l'hépatite c
EP3643792B1 (fr) 2018-10-24 2021-09-15 Fujirebio Europe N.V. Détection et analyse de variations de séquence dans un acide nucléique cible
CN117947214A (zh) * 2024-01-18 2024-04-30 圣湘生物科技股份有限公司 检测丙肝并分型的组合物、试剂盒及其用途
WO2025172242A1 (fr) 2024-02-13 2025-08-21 bioMérieux Procédé d'évaluation du risque de mort d'un patient

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
US5176994A (en) * 1988-12-21 1993-01-05 Immuno Japan Inc. Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein
US5629158A (en) 1989-03-22 1997-05-13 Cemu Bitecknik Ab Solid phase diagnosis of medical conditions
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
JP2802125B2 (ja) * 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
GB8924989D0 (en) * 1989-11-06 1989-12-28 Scotgen Ltd Method and device for the detection of antibiotic resistance
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5629153A (en) * 1990-01-10 1997-05-13 Chiron Corporation Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
CA2044296A1 (fr) * 1990-06-12 1991-12-13 Hiroaki Okamoto Amorces d'oligonucleotides, leur application dans la detection haute-fidelite des virus de l'hepatite non-a et non-b
DE69125066T2 (de) * 1990-07-11 1997-09-25 Shionogi Seiyaku K K Trading U cDNS-Sequenz und Detektion des Hepatitis C-Virus
WO1992002642A1 (fr) * 1990-08-10 1992-02-20 Chiron Corporation Diagnostics du virus non a, non b: polynucleotides utiles dans la detection du virus de l'hepatite c
US5620852A (en) 1990-11-14 1997-04-15 Hri Research, Inc. Nucleic acid preparation methods
EP0834575B1 (fr) * 1990-12-06 2001-11-28 Affymetrix, Inc. (a Delaware Corporation) Identification d'acides nucléiques dans des échantillons
EP0511559A1 (fr) * 1991-04-30 1992-11-04 F.Hoffmann-La Roche & Co. Aktiengesellschaft Réactif pour essai d'oligonucleotide
PL169880B1 (pl) * 1991-05-08 1996-09-30 Chiron Corp Sposób wytwarzania produktu hybrydyzacji z kwasem nukleinowym wirusa zapalenia watroby C PL PL PL
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
ES2111589T3 (es) * 1991-08-27 1998-03-16 Hoffmann La Roche Metodos y reactivos para la deteccion de la hepatitis c.
EP0532258A2 (fr) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucléotides et procédé pour la détection des génotypes de HCV
JPH06502770A (ja) 1991-09-12 1994-03-31 シーダーズ−サイナイ・メディカル・センター Ｃ型肝炎ウイルスｒｎａの直接検出法
US5173994A (en) * 1992-01-14 1992-12-29 The United States Of America As Represented By The Secretary Of Agriculture Fiber cleaning apparatus with air flow deflector
EP0642589A4 (fr) * 1992-05-11 1997-05-21 Ribozyme Pharm Inc Procede et reactif d'inhibition de la replication virale.
JPH06153961A (ja) 1992-11-27 1994-06-03 Imuno Japan:Kk Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法
DE69324678T2 (de) 1992-11-27 1999-12-09 Naamloze Vennootschap Innogenetics S.A., Gent Verfahren zur typisierung von hcv-isolaten
US5820852A (en) * 1996-11-26 1998-10-13 The Proctor & Gamble Company Oral compositions containing fluoride, pyrophosphate, and peroxide

Also Published As

Publication number Publication date
US6891026B2 (en) 2005-05-10
EP1197568A2 (fr) 2002-04-17
US20030036053A1 (en) 2003-02-20
AU681612B2 (en) 1997-09-04
ATE507312T1 (de) 2011-05-15
EP0637342A1 (fr) 1995-02-08
US5846704A (en) 1998-12-08
WO1994012670A3 (fr) 1994-07-21
US6548244B2 (en) 2003-04-15
EP1197568A3 (fr) 2004-04-14
CA2128528C (fr) 2012-02-14
HK1047961A1 (en) 2003-03-14
ATE179459T1 (de) 1999-05-15
US7258982B2 (en) 2007-08-21
EP1197568B1 (fr) 2011-04-27
US6887985B2 (en) 2005-05-03
US6495670B1 (en) 2002-12-17
WO1994012670A2 (fr) 1994-06-09
JP4251407B2 (ja) 2009-04-08
EP0905258A2 (fr) 1999-03-31
GR3030641T3 (en) 1999-10-29
DE69324678D1 (de) 1999-06-02
ES2133529T3 (es) 1999-09-16
EP0637342B1 (fr) 1999-04-28
US6051696A (en) 2000-04-18
US6171784B1 (en) 2001-01-09
US20020168626A1 (en) 2002-11-14
DE69334357D1 (de) 2011-06-09
DE69324678T2 (de) 1999-12-09
AU5628294A (en) 1994-06-22
CA2128528A1 (fr) 1994-06-09
US20020106638A1 (en) 2002-08-08
US20040191768A1 (en) 2004-09-30
DK0637342T3 (da) 1999-11-01
JPH07503143A (ja) 1995-04-06
EP0905258A3 (fr) 2001-01-31
JP2005040145A (ja) 2005-02-17

Similar Documents

Publication Publication Date Title
GR3030641T3 (en) Process for typing of hcv isolates.
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
WO1992019743A3 (fr) Sequences genomiques du virus de l'hepatite c utilisees en diagnostic et en therapeutique
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
AU3844095A (en) New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
DE69006472D1 (en) Zahnärztliche Zusammensetzungen, Verfahren zur Herstellung von geformten, zahnärztlichen Artikeln via "photoiniferte Polymerisation" von zahnärztlichen Zusammensetzungen und dadurch erzeugte geformte, zahnärztliche Artikel.
DE69431853D1 (de) Verfahren zur Herstellung von 1,1,3,3,3-Pentafluorpropen
EP0641215A4 (fr) Analogues de thrombomoduline resistant a la protease.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE59003791D1 (de) Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
DE59303465D1 (de) Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE3767208D1 (de) Verfahren zur herstellung von 4-acetalen des butendial-(1,4) und neue acetale des butendial-(1,4).
EP0416725A3 (en) Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE59309002D1 (de) Verfahren zur Herstellung von 6-Chlor-(6H)-dibenz-(c,e)(1,2)-oxaphosphorin
DE69431267D1 (de) Neuartige Cyclodextrin-glukanotransferase, Verfahren zu ihrer Herstellung und Verfahren zur Herstellung von Cyclodexrin mittels dieser
EP0292806A3 (en) Substituted vinyl cephalosporins, process for their preparation and their use as medicines
DE69308934D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan
DE69705995D1 (de) Verfahren zur Decarboxylierung von 2-Ketoaldonisch-Säuren
DE69010608D1 (de) Verfahren zur Herstellung von 1,1-Diarylethanen.
DE69007028D1 (de) Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.
EP0214548A3 (en) Dna sequences, recombinant dna molecules and process for the preparation of the enzyme mutarotase of acinetobacter calcoaceticus
ATE92539T1 (de) Mittel zur entschwefelung von eisenschmelzen und ein verfahren zur herstellung des mittels sowie ein verfahren zur entschwefelung von eisenschmelzen mit dem mittel.
ATE115139T1 (de) Verfahren zur herstellung von 2,4-diamino-6- piperidinyl-pyrimidin-3-n-oxid.